Traws Pharma Ownership | Who Owns Traws Pharma?

Traws Pharma Ownership Summary

Traws Pharma is owned by 6.84% institutional investors, 18.86% insiders, and 74.29% retail investors.

TRAW Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Traws Pharma	6.84%	18.86%	74.29%
Sector	Healthcare Stocks	278.70%	10.61%	-189.31%
Industry	Biotech Stocks	63.84%	10.66%	25.50%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	19	5.56%	1,732,327	48.01%	6	32.01%	12	-	4	100.00%
Dec 31, 2024	18	80.00%	1,170,406	81.08%	4	70.91%	12	20.00%	2	-
Sep 30, 2024	10	-	646,356	-	2	-	10	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 29, 2024	ORBIMED ADVISORS LLC	-	Buy	$963.48
Dec 29, 2024	ORBIMED ADVISORS LLC	-	Buy	$1.29M
Dec 29, 2024	CAUTREELS WERNER	Chief Executive Officer	Buy	$963.48
Dec 29, 2024	CAUTREELS WERNER	Chief Executive Officer	Buy	$1.29M
Dec 29, 2024	TPAV, LLC	-	Buy	$963.48

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	8	-
2024 Q3	-	-
2024 Q2	-	-

TRAW Ownership FAQ

Who Owns Traws Pharma?

Traws Pharma shareholders are primarily institutional investors at 6.84%, followed by 18.86% insiders and 74.30% retail investors. The average institutional ownership in Traws Pharma's industry, Biotech Stocks , is 63.84%, which Traws Pharma falls below.

Does Blackrock own Traws Pharma?

BlackRock is not among the top 10 institutional shareholders of Traws Pharma.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools